معرفی
Christopher Fairley is Professor of Public Health at Monash University and Director of the Melbourne Sexual Health Centre, a leading institution in sexual health research and clinical care. He is also affiliated with the Centre to Impact Antimicrobial Resistance. His work is recognized internationally for advancing public health strategies in sexually transmitted infections (STIs).
- Professor of Public Health, Monash University
- Director, Melbourne Sexual Health Centre
- Partner Investigator, ARC Research Hub to Combat Antimicrobial Resistance
- Editor, Sexual Health Journal (2004–2023)
- President, Australasian Chapter of Sexual Health Medicine (2020–2022)
- Assistant Secretary, International Union against Sexually Transmitted Infections (IUSTI)
His research focuses on the public health control of STIs, including HIV, HPV, syphilis, and Mycoplasma genitalium. He investigates clinical service effectiveness, antimicrobial resistance, vaccination impact, and digital health innovations. His work contributes to UN Sustainable Development Goals in health and well-being.
The recent publications highlight a strong trend toward integrating artificial intelligence and digital tools into sexual health services, alongside rigorous epidemiological studies on resistance patterns, service delivery, and health-seeking behavior. His research spans clinical trials, systematic reviews, and public health surveillance.
- Officer of the Order of Australia (AO), 2018
- RACP Eric Susman Prize, 2018
- Fellow, Australian Academy of Health and Medical Sciences (AAHMS), 2018
- ASRHA Innovation Award (2021)
- Australian Museum Eureka Prize (2022)
- CAPHIA Research Excellence Award (Team, 2023)
- City of Melbourne LGBTIQA+ Award (2023)
Professor Fairley has supervised 37 doctoral students and leads multiple NHMRC and industry-funded research projects, including Optimising STI Control and eSTI: A Digital Sexual Health Hub. He serves on the boards of IUSTI and ISSTDR and has been a frequent plenary speaker at international conferences. His leadership in national and global STI policy is evident through his editorial and committee roles.
He leads and collaborates on major research teams such as the Australian STI Research Group and the ARC Research Hub to Combat Antimicrobial Resistance, working with institutions across Australia and internationally to improve sexual health outcomes.
